Clinical Trial Update: Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on safety and immunogenicity of two trivalent subunit influenza vaccines in healthy adults; results completed and posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Prophylaxis

Drugs mentioned

• trivalent subunit influenza vaccines (two formulations)

Snippet

Sponsor: Novartis Vaccines | Conditions: Prophylaxis: Influenza | Phase 3 | Status: COMPLETED | Results posted: 2015-08-07